Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study

Munjal, S; Bennett, A

Munjal, S (reprint author), Promius Pharma, 107 Coll Rd East, Princeton, NJ 08540 USA.

NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017; 13 ( ): 2797

Abstract

Background: The objective of this proof-of-concept study was to assess the safety, efficacy, and potential for dose response of a new oral liquid form......

Full Text Link